1st Circ. Denies Bid To Stall Solodyn Pay-For-Delay Trial
By Alison Noon · February 13, 2018, 8:26 PM EST
The First Circuit on Monday denied an attempt by Valeant Pharmaceuticals subsidiary Medicis Pharmaceutical Corp. to stall a March trial slated to decide whether the company paid generic-drug makers to stay...
To view the full article, register now.